Cargando…

Ciprofloxacin Use in Hospitalized Children: Approved or Off-label?

OBJECTIVE: Fluoroquinolones are not routinely used as the first-line antimicrobial therapy in pediatrics. The American Academy of Pediatrics (AAP) and the United States Food and Drug Administration (FDA) approved fluoroquinolones on certain indications in children. The aim of this study was to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faghihi, Toktam, Tekmehdash, Leila Yavari, Radfar, Mania, Gholami, Kheirollah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787903/ https://www.ncbi.nlm.nih.gov/pubmed/29417077 http://dx.doi.org/10.4103/jrpp.JRPP_17_27

Ejemplares similares

Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial
por: Nasiripour, Somayyeh, et al.
Publicado: (2014)

Pediatric hospital admission due to adverse drug reactions: Report from a tertiary center
por: Gholami, Kheirollah, et al.
Publicado: (2015)

A Randomized Clinical Trial Evaluating the Efficacy of Colistin Loading Dose in Critically Ill Children
por: Fatehi, Shiva, et al.
Publicado: (2019)

Growth Hormone Utilization Review in a Pediatric Primary Care Setting
por: Sayarifard, Fatemeh, et al.
Publicado: (2017)

Ciprofloxacin/corticosteroids/dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Vancomycin Pharmacokinetic Parameters in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
por: Ghehi, Maryam Taghizadeh, et al.
Publicado: (2013)

Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use
por: Conti, Francesca, et al.
Publicado: (2023)

Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options
por: Isidro, Maria Luisa, et al.
Publicado: (2010)

Rituximab utilization for approved and off‐label nononcology indications and patients’ experiences with the Patient Alert Card
por: Sarsour, Khaled, et al.
Publicado: (2020)

Off-label medications in the treatment of hospitalized children with atopic dermatitis
por: Niedźwiedź, Michał, et al.
Publicado: (2022)

Bortezomib/ciprofloxacin/tocilizumab: Various toxicities and lack of efficacy with an off label treatment: 2 case reports
Publicado: (2021)

Frequency of prescriptions of off-label drugs and drugs not approved for pediatric use in primary health care in a southern municipality of Brazil
por: Gonçalves, Marcele Giacomin, et al.
Publicado: (2016)

Evaluation of anti-tuberculosis induced adverse reactions in hospitalized patients
por: Gholami, Kheirollah, et al.
Publicado: (2006)

Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
por: Lenk, Christian, et al.
Publicado: (2009)

Using Twitter data to understand public perceptions of approved versus off-label use for COVID-19-related medications
por: Hua, Yining, et al.
Publicado: (2022)

The Use of Off-Label Medications in Newborn Infants Despite an Approved Alternative Being Available—Results of a National Survey
por: Veldman, Alex, et al.
Publicado: (2022)

The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use
por: Yunusa, Ismaeel, et al.
Publicado: (2020)

Current ciprofloxacin usage in children hospitalized in a referral hospital in Paris
por: Yang, Zhi-Tao, et al.
Publicado: (2013)

Off‐label drug use in hospitalized children: a prospective observational study at Gondar University Referral Hospital, Northwestern Ethiopia
por: Tefera, Yonas G., et al.
Publicado: (2017)

Safety and Efficacy of Off-label and Unlicensed Medicines in Children
por: Lee, Ji-Hyun, et al.
Publicado: (2018)

Choosing Appropriate Theories for Understanding Hospital Reporting of Adverse Drug Events, a Theoretical Domains Framework Approach
por: Shalviri, Gloria, et al.
Publicado: (2018)

Usefulness of Danaparoid sodium in patients with Heparin-induced thrombocytopenia after cardiac surgery
por: Foroughinia, Farzaneh, et al.
Publicado: (2015)

Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
por: Van Norman, Gail A.
Publicado: (2023)

Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach
por: Mirbaha, Fariba, et al.
Publicado: (2015)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
por: WANG, Weilan, et al.
Publicado: (2013)

Adverse drug events leading to emergency department visits at an eye hospital: A brief report
por: Alizadeh, Safa, et al.
Publicado: (2017)

Parents’ awareness and perspective on off-label medicines use in children
por: Saiyed, Mohd Masnoon, et al.
Publicado: (2015)

Adverse reactions of Methylphenidate in children with attention deficit-hyperactivity disorder: Report from a referral center
por: Khajehpiri, Zahra, et al.
Publicado: (2014)

Incidence of unlicensed and off-label prescription in children
por: Langerová, Petra, et al.
Publicado: (2014)

Off-label prescribing for allergic diseases in children
por: Silva, Diana, et al.
Publicado: (2014)

Adverse drug reactions induced by cardiovascular drugs in outpatients
por: Gholami, Kheirollah, et al.
Publicado: (2008)

Off-label use of antimicrobials among hospitalized children: a retrospective study of 3,406 patients
por: Tang, Lin, et al.
Publicado: (2023)

Impact of Protocol Implementation on Rationalization of Albumin Use in a Tertiary Care Teaching Hospital in Tehran, Iran
por: Ebrahimpour, Sholeh, et al.
Publicado: (2018)

Nephroprotective Effects of L-Carnitine against Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Open-Labeled Clinical Trial
por: Mohammadi, Mohammad, et al.
Publicado: (2017)

The Evaluation of Albumin Utilization in a Teaching University Hospital in Iran
por: Jahangard-Rafsanjani, Zahra, et al.
Publicado: (2011)

Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis
por: Achar, Jay, et al.
Publicado: (2017)

A Comparison of Safety Information in Drug Labeling at the Initial Approval of New Drugs Approved Both in Japan and the United States
por: Hoshino, Yuko, et al.
Publicado: (2022)

Prediction of ciprofloxacin resistance in hospitalized patients using machine learning
por: Mintz, Igor, et al.
Publicado: (2023)

Comparison of Efficacy and Safety of Two Different Enoxaparin Products in Prevention of Venous Thromboembolism Following Major Obstetric-gynecological Surgeries: An Open-label Randomized Clinical Trial
por: Abdolvand, Manoochehr, et al.
Publicado: (2019)

When is off-label off-road?
por: de Vries, E G E, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q2o306g712689n4v9lcovl1f9j